in association with Your pharmacy training paner


UCA-NI PHARMACY CONFERENCE 2020


Sunday 29 March 2020 Visit: www.pharmacyinfocus.com REGISTER NOW


Over-the-counter analgesics: the science and the myths


AIM To challenge myths held by pharmacists about the safety and efficacy of paracetamol, ibuprofen and codeine medicines in the management of common mild to moderate pain.


OBJECTIVES Having attended this breakout session delegates will: • Appreciate the comparative efficacy of ibuprofen and paracetamol


• Understand the role, if any, of codeine in enhancing analgesic efficacy


• List the main side-effects of Ibuprofen, paracetamol and codeine


• List the main contra-indications for ibuprofen, paracetamol and codeine


Patient Group Directions: running successful flu and travel clinics


AIM To make customers and patients aware that community pharmacies can provide a range of medicines and services – particularly with reference to travel and the flu vaccine - through PGDs.


OBJECTIVES Having attended this breakout session delegates will: • Appreciate the benefits that PGDs can bring to your patients and, by association, your pharmacy business


• Understand how you can potentially reduce health inequalities by providing access to hard-to-reach patient groups


• Appreciate how expanding the range of services you can offer can increase your footfall and your revenue streams


• Improve the visibility of your business in the local community in order to develop your potential market


Life-saving injectable: adrenaline auto-injector


AIM To learn about the adrenaline auto- injector made by ALK, how to use it, and the benefits it can bring to patients.


OBJECTIVES Having attended this breakout session delegates will: • Have a good understanding of anaphylaxis and its management


• Understand the gaps in current practice surrounding the provision of AAIs following an anaphylactic episode and their subsequent use


• Feel confident in addressing management gaps with ongoing advice and training for patients and parents/carers


• Be aware of the different AAIs, their similarities and differences, and the support available


• Understand how to source and demonstrate patient support items such as the app, website or patient literature


Electronic/controlled drug registers/electronic adverse event reporting


AIM To understand how Pharmsmart can help your pharmacy with the time- consuming administration required for dealing with controlled drugs.


OBJECTIVES Following this workshop, you should understand how Pharmsmart can: • Provide automatic analysis of patient safety elements in the dispensary


• Give you access to near miss recording and guided root cause analysis


• Offer a lightning-fast electronic CD register


• Provide your pharmacy with an SOP manager, cleaning and data checking log and staff clocking in/out system


Falsified Medicines Directive – and other IT challenges for Community Pharmacy


AIM To outline the challenges posed by the integration of FMD in the community pharmacy, and other IT ‘hot topics’ in 2020.


OBJECTIVES Having attended this breakout session delegates will: • Have an overview of FMD and its benefits for patient safety


• Hold a discussion of the challenges posed


• Understand the data your pharmacy holds and GDPR implications


• Understand viral attacks and how best to mitigate against these


• Understand IT hot topics such as withdrawal of support for Windows 7


Life-saving injectable: Naloxone legal responsibilities


AIM To learn about the development of naloxone and how it went from being a ‘hospital only’ product to one that is supplied to the community


OBJECTIVES Having attended this breakout session delegates will: • Be able to recognise the signs and symptoms of overdose


• Know how to make appropriate interventions and administer naloxone


• Fully understand the implications of the amendment to the Medicines Act in October 2015


• Know about the legislation surrounding the use of Take-Home naloxone kits through both community pharmacy and peer-to- peer supply


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64